Three-ring PI3K and/or mTOR inhibitor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9284315
APP PUB NO 20150166539A1
SERIAL NO

14358906

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present application relates to a compound as represented by general formula (I), a pharmaceutically acceptable salt, ester, solvate or stereoisomer thereof, preparation method of the compounds, a pharmaceutical composition containing the compounds, uses thereof in the preparation of drugs for treating and/or preventing proliferative diseases, and a method using the compounds to treat and/or prevent proliferative diseases. R1, R2, R3, R4, R5, R6, X, A and B in the formula are as defined in the specification.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XUANZHU PHARMA CO LTD2518 TIANCHEN STREET NATIONAL HIGH-TECH DEVELOPMENT ZONE JINAN-CITY SHANDONG PROVINCE 250101

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Wu, Frank Jinan, CN 101 2813
Zhang, Yan Jinan, CN 881 7426

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00